Rocket Lab Successfully Deploys Sixth Earth-Imaging Satellite for iQPS
Globenewswire· 2025-11-06 05:45
Live broadcast of Rocket Lab's 74th launch and sixth for iQPS. LONG BEACH, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched its 74th Electron mission and deployed the latest satellite to orbit for Institute for Q-shu Pioneers of Space, Inc. (iQPS). The mission was Rocket Lab’s sixth dedicated mission for iQPS, making Rocket Lab the most prolific launcher o ...
Benitec Biopharma Inc. Announces Proposed Public Offering
Globenewswire· 2025-11-06 05:43
HAYWARD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA- directed RNA interference (“ddRNAi”) “Silence and Replace” platform, today announced that it has commenced an underwritten public offering of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and intends to conduct a concurrent regis ...
Monroe Capital Corporation BDC Announces Third Quarter 2025 Results
Globenewswire· 2025-11-06 05:35
CHICAGO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (NASDAQ: MRCC) today announced its financial results for the third quarter ended September 30, 2025. Except where the context suggests otherwise, the terms “Company,” “we,” “us,” and “our” refer to Monroe Capital Corporation (together with its subsidiaries). Third Quarter 2025 Financial Highlights Net Investment Income ("NII") of $1.8 million, or $0.08 per shareAdjusted Net Investment Income (a non-GAAP measure described below) of $1.9 mi ...
Arq Reports Third Quarter 2025 Results
Globenewswire· 2025-11-06 05:33
Generated revenue of $35 million, driven by strong performance of the foundational PAC business Reported Adjusted EBITDA of $5.2 million, achieving sixth consecutive quarter of positive Adjusted EBITDA Achieved 7% price increase year-over-year Achieved initial commercial phase GAC production and sales GREENWOOD VILLAGE, Colo., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Arq, Inc. (NASDAQ: ARQ) (the "Company" or "Arq"), a producer of activated carbon and other environmentally efficient carbon products for use in purif ...
MKS Inc. Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-11-06 05:30
Revenue of $988 million, at the high end of guidance GAAP net income of $74 million and net income per diluted share of $1.10, each in the upper half of guidanceAdjusted EBITDA of $240 million and Non-GAAP net earnings per diluted share of $1.93, each in the upper half of guidanceOperating cash flow of $197 million and free cash flow of $147 million, enabling continued focus on the prepayment of debt and reducing net leverage ratio to 3.9x ANDOVER, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: ...
Novo Nordisk Wegovy® users achieved waist and BMI targets linked to improved health and low risk of obesity-related complications
Globenewswire· 2025-11-06 05:30
Unlike many other diseases, there are no set guidelines on treatment targets for obesity, and outcomes often rely on percentage weight loss onlyBody mass index (BMI) and waist-to-height ratio (a measurement of unhealthy waist size) represent important obesity treatment targets, associated with a lower risk of obesity-related complicationsA study of people with obesity (STEP UP trial) showed that more people taking Wegovy® achieved a BMI under 27 and a waist-to-height ratio of less than 0.53, compared to non ...
Duos Technologies Group Sets Third Quarter 2025 Earnings Call for Wednesday, November 12, 2025, at 4:30 PM ET
Globenewswire· 2025-11-06 05:30
JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT) announced it will host its first-ever live video earnings call on Wednesday, November 12, 2025, at 4:30 p.m. ET, to discuss financial results for the third quarter ended September 30, 2025. Financial results will be issued via press release prior to the conference. The live-streamed event will feature prepared remarks from management followed by a Q&A session. Investors and interested ...
LanzaTech Secures €40 Million EU Innovation Fund Grant for first-of-its-kind integrated CCUS project in Norway
Globenewswire· 2025-11-06 05:30
SKOKIE, Ill., Nov. 05, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA), a leader in industrial carbon recycling, is thrilled to announce the awarding of a €40 million grant from the European Union’s Innovation Fund, subject to the finalization of the grant agreement. The project, featuring the first commercial deployment of LanzaTech’s second-generation bioreactor, aims to produce 23.5 kt (~8M U.S. gallons) of ethanol per year by consuming smelter furnace greenhouse gases (GHG) from the Porsg ...
PharmaCorp Announces C$15 Million Bought Deal Public Offering
Globenewswire· 2025-11-06 05:26
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 05, 2025 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to announce that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) co-led by Canaccord Genuity Corp. and Acumen ...
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
Globenewswire· 2025-11-06 05:20
-- Lung cancer programs progressing with interim data updates expected in Q4 2025 -- -- Topline data from OnPrime Phase 3 ovarian cancer registrational trial expected in the second half of 2026 -- -- Cash, cash equivalents, short-term investments and restricted cash of $21.0 million as of September 30, 2025 -- WESTLAKE VILLAGE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third quarter o ...